We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TRANSPARENT PRICING COULD GET BIO-PHARMA OFF DEFENSIVE
TRANSPARENT PRICING COULD GET BIO-PHARMA OFF DEFENSIVE
June 7, 2004
Greater transparency about the pricing decisions for biotech and pharmaceutical products could ease growing public and political outrage over the high cost of drugs, according to industry experts at the Biotechnology Industry Organization 2004 convention in San Francisco.